Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study
Abstract Background Current guidelines recommend life-long use of statin for patients with type 2 diabetes (T2D), however, a number of patients discontinue statin therapy in clinical practice. We aimed to estimate the optimal statin therapy including statin therapy duration, statin intensity, and lo...
Main Authors: | Ji Yoon Kim, Jimi Choi, Sin Gon Kim, Nam Hoon Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-022-01466-z |
Similar Items
-
Association of serum cholesterol with Parkinson's disease in a cohort of statin‐free individuals
by: Yukai Lv, et al.
Published: (2022-01-01) -
Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
by: Ted Okerson, et al.
Published: (2017-03-01) -
High‐Intensity Versus Non‐High‐Intensity Statins in Patients Achieving Low‐Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention
by: Juwon Kim, et al.
Published: (2018-11-01) -
Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins
by: Yosuke Furuya, et al.
Published: (2016-06-01) -
Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study
by: Yuqi Zhao, et al.
Published: (2023-01-01)